Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Valeant's semantic innovation, Pfizer's future and the slow trickle of biotech IPOs
Fierce editors discuss a fascinating Valeant Pharmaceuticals conference call, Pfizer's desire for a big buyout and the creaky world of biotech IPOs.
About This Episode
Valeant's semantic innovation, Pfizer's future and the slow trickle of biotech IPOs is an episode from FierceBiotech Radio. Fierce editors discuss a fascinating Valeant Pharmaceuticals conference call, Pfizer's desire for a big buyout and t...
Podcast
This episode belongs to FierceBiotech Radio.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Oct 29, 2015, 25:08 long, audio available.
Related Episodes
Continue listening to more episodes from FierceBiotech Radio.
